The strongest version of the argument for this blend is that L-carnitine has documented effects on fatty acid transport and oxidation, tirzepatide creates a metabolic state where enhanced fatty acid oxidation could theoretically be beneficial, and combining them in a single injection is convenient
Additionally, in animal models, riboflavin deficiency was also found to induce down-regulated expression of key osteogenic markers in the femur, including Runx2, Osterix, and BMP-2/Smad1/5/9 cascade [12]
Deletion of Dpp4 in hepatocytes lowers portal DPP4 activity and increases portal concentrations of bioactive GLP-1 and GIP
Consequently carnitine, either introduced in the diet or synthesizes de novo in the liver and kidney, must be actively concentrated from the blood into fatty acid metabolizing organs 6
Resveratrol (from Japanese Knotweed Root) 75mg
GLP-1 medications FDA-approved to treat Type 2 diabetes, such as Ozempic and Mounjaro, will remain covered for TFL and other TRICARE beneficiaries